• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻腔接种转涎酶抗原加 CpG 佐剂可诱导针对结膜克氏锥虫挑战的粘膜免疫保护。

Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.

机构信息

Department of Molecular Microbiology and Immunology, Saint Louis University Medical Center, St. Louis, Missouri 63104, USA.

出版信息

Infect Immun. 2010 Mar;78(3):1333-8. doi: 10.1128/IAI.00278-09. Epub 2010 Jan 4.

DOI:10.1128/IAI.00278-09
PMID:20048046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2825935/
Abstract

Trypanosoma cruzi is an intracellular protozoan parasite capable of infecting through mucosal surfaces. Our laboratory has previously elucidated the anatomical routes of infection after both conjunctival and gastric challenge in mice. We have shown that chronically infected mice develop strong immune responses capable of protecting against subsequent rechallenge with virulent parasites through gastric, conjunctival, and systemic routes of infection. We have also shown that intranasal immunizations with the unique T. cruzi trans-sialidase (TS) antigen protect against gastric and systemic T. cruzi challenge. In the current work we have investigated the ability of purified TS adjuvanted with CpG-containing oligonucleotides to induce immunity against conjunctival T. cruzi challenge. We confirm that intranasal vaccinations with TS plus CpG induce TS-specific T-cell and secretory IgA responses. TS-specific secretory IgA was detectable in the tears of vaccinated mice, the initial body fluid that contacts the parasite during infectious conjunctival exposures. We further show that intranasal vaccinations with TS plus CpG protect against conjunctival T. cruzi challenge, limiting local parasite replication at the site of mucosal invasion and systemic parasite dissemination. We also provide the first direct evidence that mucosal antibodies induced by intranasal TS vaccination can inhibit parasite invasion.

摘要

克氏锥虫是一种能够通过黏膜表面感染的细胞内原生动物寄生虫。我们的实验室之前已经阐明了在小鼠的结膜和胃刺激后感染的解剖途径。我们已经表明,慢性感染的小鼠会产生强烈的免疫反应,能够通过胃、结膜和全身感染途径保护免受随后的强毒寄生虫再攻击。我们还表明,用独特的克氏锥虫转涎酸酶(TS)抗原经鼻内免疫可预防胃和全身克氏锥虫感染。在目前的工作中,我们研究了用含有 CpG 寡核苷酸佐剂的纯化 TS 诱导针对结膜克氏锥虫感染的免疫能力。我们证实,用 TS 加 CpG 进行鼻内接种可诱导 TS 特异性 T 细胞和分泌型 IgA 反应。在接种疫苗的小鼠的泪液中可检测到 TS 特异性分泌型 IgA,这是在传染性结膜暴露期间接触寄生虫的初始体液。我们进一步表明,用 TS 加 CpG 进行鼻内接种可预防结膜克氏锥虫感染,限制了黏膜入侵部位的局部寄生虫复制和全身寄生虫传播。我们还提供了第一个直接证据,证明经鼻内 TS 接种诱导的黏膜抗体可以抑制寄生虫入侵。

相似文献

1
Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.经鼻腔接种转涎酶抗原加 CpG 佐剂可诱导针对结膜克氏锥虫挑战的粘膜免疫保护。
Infect Immun. 2010 Mar;78(3):1333-8. doi: 10.1128/IAI.00278-09. Epub 2010 Jan 4.
2
Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.与含CpG基序的寡脱氧核苷酸混合的转唾液酸酶重组蛋白可诱导涉及CD8 + CTL和B细胞介导的交叉启动的保护性粘膜和全身性克氏锥虫免疫。
J Immunol. 2007 Nov 15;179(10):6889-900. doi: 10.4049/jimmunol.179.10.6889.
3
Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.共给药编码白细胞介素-15 的质粒 DNA 可改善针对克氏锥虫的基因疫苗的长期保护作用。
PLoS Negl Trop Dis. 2011 Mar 8;5(3):e983. doi: 10.1371/journal.pntd.0000983.
4
Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.1型免疫为抵抗黏膜和全身性克氏锥虫攻击提供了最佳保护。
Infect Immun. 2002 Dec;70(12):6715-25. doi: 10.1128/IAI.70.12.6715-6725.2002.
5
Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.一种免疫显性寄生虫抗原的共刺激作用反常地阻碍了最佳CD8 T细胞保护性免疫的诱导。
PLoS Pathog. 2016 Sep 19;12(9):e1005896. doi: 10.1371/journal.ppat.1005896. eCollection 2016 Sep.
6
Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.一种跨唾液酸酶-免疫刺激复合物基质亚单位候选疫苗预防实验性恰加斯病的效果。
Vaccine. 2015 Mar 3;33(10):1274-83. doi: 10.1016/j.vaccine.2015.01.044. Epub 2015 Jan 25.
7
Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.鼻内免疫乳杆菌衍生的转涎酶抗原加 c-di-AMP 可预防急性口服 T. cruzi 感染。
Vaccine. 2022 Apr 1;40(15):2311-2323. doi: 10.1016/j.vaccine.2022.02.071. Epub 2022 Mar 9.
8
Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.比较通过用裸DNA或重组蛋白递送的寄生虫抗原免疫引发的针对克氏锥虫感染的抗体和保护性免疫反应。
Parasite Immunol. 1999 Feb;21(2):103-10. doi: 10.1046/j.1365-3024.1999.00201.x.
9
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection.针对 gp82 的免疫反应为抵抗肠道中的克氏锥虫感染提供了保护。
Mem Inst Oswaldo Cruz. 2010 Aug;105(5):687-91. doi: 10.1590/s0074-02762010000500015.
10
DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.编码CD4+和CD8+ T细胞表位的DNA序列对于用克氏锥虫基因进行DNA疫苗接种诱导的有效保护性免疫很重要。
Infect Immun. 2001 Sep;69(9):5477-86. doi: 10.1128/IAI.69.9.5477-5486.2001.

引用本文的文献

1
Fighting Strategies Against Chagas' Disease: A Review.对抗恰加斯病的斗争策略:综述
Pathogens. 2025 Feb 12;14(2):183. doi: 10.3390/pathogens14020183.
2
Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model.鼻内转唾液酸酶疫苗可减轻临床前口腔恰加斯病模型中的急性和慢性病理变化。
Vaccines (Basel). 2024 Oct 15;12(10):1171. doi: 10.3390/vaccines12101171.
3
Treatments and the Perspectives of Developing a Vaccine for Chagas Disease.恰加斯病的治疗方法及开发疫苗的前景
Vaccines (Basel). 2024 Aug 1;12(8):870. doi: 10.3390/vaccines12080870.
4
Immunization with a Trypanosoma cruzi cyclophilin-19 deletion mutant protects against acute Chagas disease in mice.用克氏锥虫亲环蛋白-19缺失突变体进行免疫可保护小鼠免受急性恰加斯病的侵害。
NPJ Vaccines. 2023 Apr 25;8(1):63. doi: 10.1038/s41541-023-00647-5.
5
Vaccine Design against Chagas Disease Focused on the Use of Nucleic Acids.针对恰加斯病的疫苗设计:聚焦于核酸的应用
Vaccines (Basel). 2022 Apr 12;10(4):587. doi: 10.3390/vaccines10040587.
6
Galectins in Chagas Disease: A Missing Link Between Infection, Inflammation, and Tissue Damage.恰加斯病中的半乳糖凝集素:感染、炎症与组织损伤之间缺失的环节
Front Microbiol. 2022 Jan 3;12:794765. doi: 10.3389/fmicb.2021.794765. eCollection 2021.
7
Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.一种免疫显性寄生虫抗原的共刺激作用反常地阻碍了最佳CD8 T细胞保护性免疫的诱导。
PLoS Pathog. 2016 Sep 19;12(9):e1005896. doi: 10.1371/journal.ppat.1005896. eCollection 2016 Sep.
8
Recent progress concerning CpG DNA and its use as a vaccine adjuvant.关于 CpG DNA 及其作为疫苗佐剂的最新进展。
Expert Rev Vaccines. 2014 Feb;13(2):299-312. doi: 10.1586/14760584.2014.863715. Epub 2013 Nov 26.
9
CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits.CpG 佐剂增强梅毒螺旋体 DNA 疫苗在兔中的黏膜免疫原性和效果。
Hum Vaccin Immunother. 2013 Apr;9(4):753-60. doi: 10.4161/hv.23064. Epub 2013 Apr 1.
10
Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses.纤维连接蛋白结合肽(FBP)与细粒棘球绦虫四跨膜蛋白 3 融合的黏膜佐剂活性:系统和局部抗体反应。
PLoS Negl Trop Dis. 2012;6(9):e1842. doi: 10.1371/journal.pntd.0001842. Epub 2012 Sep 27.

本文引用的文献

1
Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.与含CpG基序的寡脱氧核苷酸混合的转唾液酸酶重组蛋白可诱导涉及CD8 + CTL和B细胞介导的交叉启动的保护性粘膜和全身性克氏锥虫免疫。
J Immunol. 2007 Nov 15;179(10):6889-900. doi: 10.4049/jimmunol.179.10.6889.
2
Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.克氏锥虫结膜感染的侵袭解剖途径及保护性黏膜免疫
Infect Immun. 2006 Oct;74(10):5549-60. doi: 10.1128/IAI.00319-06.
3
Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.使用苯硝唑治疗慢性恰加斯病与不治疗的长期心脏结局:一项非随机试验
Ann Intern Med. 2006 May 16;144(10):724-34. doi: 10.7326/0003-4819-144-10-200605160-00006.
4
Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.1型免疫为抵御黏膜侵袭性细胞内病原体提供了最佳的黏膜和全身保护。
Infect Immun. 2005 Aug;73(8):4934-40. doi: 10.1128/IAI.73.8.4934-4940.2005.
5
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.在实验性恰加斯病的慢性期用苄硝唑治疗可减少心脏病变。
Antimicrob Agents Chemother. 2005 Apr;49(4):1521-8. doi: 10.1128/AAC.49.4.1521-1528.2005.
6
Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.用编码无鞭毛体表面蛋白-2和转唾液酸酶的基因接种后,在高度易感小鼠品系中对克氏锥虫感染的保护性免疫。
Hum Gene Ther. 2004 Sep;15(9):878-86. doi: 10.1089/hum.2004.15.878.
7
Involvement of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 in adhesion to gastric mucin and invasion of epithelial cells.克氏锥虫循环后期锥鞭毛体表面分子gp82在黏附胃黏蛋白及侵袭上皮细胞中的作用。
Infect Immun. 2003 Jan;71(1):557-61. doi: 10.1128/IAI.71.1.557-561.2003.
8
Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.1型免疫为抵抗黏膜和全身性克氏锥虫攻击提供了最佳保护。
Infect Immun. 2002 Dec;70(12):6715-25. doi: 10.1128/IAI.70.12.6715-6725.2002.
9
DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.编码CD4+和CD8+ T细胞表位的DNA序列对于用克氏锥虫基因进行DNA疫苗接种诱导的有效保护性免疫很重要。
Infect Immun. 2001 Sep;69(9):5477-86. doi: 10.1128/IAI.69.9.5477-5486.2001.
10
Evolution of the clinical and epidemiological knowledge about Chagas disease 90 years after its discovery.查加斯病发现90年后临床及流行病学知识的演变。
Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:81-8. doi: 10.1590/s0074-02761999000700008.